Gene · 1375
Papers1,685
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,685
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Changes in the expression of genes related to intestinal fatty acid oxidation and carnitine metabolism in patients with ulcerative colitis]. | Zhonghua Yi Xue Za Zhi | 2024 | 39307717 | PubTator, text mining | PubMed |
| Baicalin ameliorates heat stress-induced hepatic injury and intestinal microecology dysbiosis in late gestational mice. | Ecotoxicol Environ Saf | 2024 | 39137469 | PubTator, text mining | PubMed |
| MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression. | Br J Cancer | 2024 | 38906969 | PubTator, text mining | PubMed |
| Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation? | Circulation | 2024 | 38739695 | PubTator, text mining | PubMed |
| 2-Methoxyestradiol ameliorates doxorubicin-induced cardiotoxicity by regulating the expression of GLUT4 and CPT-1B in female rats. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38652282 | PubTator, text mining | PubMed |
| HucMSC-Exo Induced N2 Polarization of Neutrophils: Implications for Angiogenesis and Tissue Restoration in Wound Healing. | Int J Nanomedicine | 2024 | 38638364 | PubTator, text mining | PubMed |
| Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics. | Adv Sci (Weinh) | 2024 | 38627980 | PubTator, text mining | PubMed |
| Carnitine palmitoyltransferase 1B mediates gemcitabine resistance in pancreatic cancer. | Surgery | 2024 | 38527919 | PubTator, text mining | PubMed |
| Identification and analysis of prognostic metabolic characteristics in colon adenocarcinoma. | Heliyon | 2024 | 38509965 | PubTator, text mining | PubMed |
| IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia. | J Immunol | 2024 | 38497670 | PubTator, text mining | PubMed |
| Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. | iScience | 2024 | 38439961 | PubTator, text mining | PubMed |
| Multiple databases analyzed the prognosis prediction of renin secretion pathway-related genes in renal clear cell carcinoma and immunotherapy. | Transl Cancer Res | 2024 | 38410221 | PubTator, text mining | PubMed |
| Integrating artificial intelligence in osteosarcoma prognosis: the prognostic significance of SERPINE2 and CPT1B biomarkers. | Sci Rep | 2024 | 38383657 | PubTator, text mining | PubMed |
| Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy. | Lipids Health Dis | 2024 | 38302980 | PubTator, text mining | PubMed |
| CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer. | Surgery | 2024 | 38302326 | PubTator, text mining | PubMed |
| Mitochondrial-to-nuclear communications through multiple routes regulate cardiomyocyte proliferation. | Cell Regen | 2024 | 38291287 | PubTator, text mining | PubMed |
| Chrysoeriol Improves the Early Development Potential of Porcine Oocytes by Maintaining Lipid Homeostasis and Improving Mitochondrial Function. | Antioxidants (Basel) | 2024 | 38275647 | PubTator, text mining | PubMed |
| Sucrose-Enriched and Carbohydrate-Free High-Fat Diets Distinctly Affect Substrate Metabolism in Oxidative and Glycolytic Muscles of Rats. | Nutrients | 2024 | 38257179 | PubTator, text mining | PubMed |
| Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. | J Exp Clin Cancer Res | 2024 | 38245798 | PubTator, text mining | PubMed |
| MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning. | Cell Biosci | 2024 | 38245780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1375/papers?page=5